Tirzepatide has quickly become one of the most talked-about medications for diabetes and weight management since its first approval in 2022, but it can also be expensive
Other GLP-1 or GIP receptor agonists these should not be used concurrently with tirzepatide
Tirzepatide follows a structured dose-escalation protocol, starting at 2.5 mg weekly and increasing by 2.5 mg increments every four weeks as tolerated
Regarding mortality, a total of 16 deaths were reported in semaglutide treatment groups, 8 deaths were reported in active comparator groups (empagliflozin, sitagliptin, liraglutide, and dulaglutide), and 3 deaths were reported in placebo groups
Highly proliferative immune cells undergo accelerated telomere attrition with each antigen-driven expansion, eventually reaching replicative senescence and acquiring a SASP (senescence-associated secretory phenotype) that contributes to chronic low-grade inflammation (inflammaging)
Zepbound has also been shown to improve related cardiometabolic markers, including reductions in blood pressure, cholesterol, and visceral fat in people with obesity